Healthcare Professional Check

This website is intended for diabetes healthcare professionals. Click one of the options below to access the content.

You are here

Coming Soon

Unmet Needs and Rationale for Combination Therapies for Primary Care Physicians

for Primary Care Physicians

In this course, you will learn about the rationale for adding a glucagon-like peptide-1 (GLP-1) receptor agonist to basal insulin therapy. The complementary effects of basal insulin–GLP-1 receptor agonist combination therapy will be discussed in terms of glycaemic control, change in body weight, and risk of hypoglycaemia. After completing this course, you will be able to identify patients for whom basal insulin–GLP-1 receptor agonist combination therapy may be a viable option, and also learn some practical tips on how to best manage these patients. Sign up to the E-Alert to be updated on all new publications.

  • Roundtable

    Current treatment options in patients with type 2 diabetes (T2D)

    • Treatment recommendations targeted at minimizing weight gain and risk of hypoglycaemia

    • Consider earlier initiation of GLP-1 RA to an insulin regimen
    • The effects of GLP-1 RA on PPG, FPG, and mechanisms for weight loss
    • Rationale for basal insulin GLP-1 RA combination
  • Webcast

    Patient counselling – evolving case

    • A case study from clinical practice
  • Selected article

  • Selected article

  • Selected article

Courses are now online!

Register for the Insulin Educational program and start any available content whenever you want. You can sign up to the E-alert list to be notified when new courses or course modules are uploaded.

Search this site

Search form


Developed by Elsevier B.V., supported by an unrestricted educational grant from Novo Nordisk